NCT04641260View on ClinicalTrials.gov

A Study to Assess the Effect of Food With Fezolinetant in Healthy Female Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

November 20, 2020

Primary Completion Date

February 12, 2021

Study Completion Date

February 21, 2021

Conditions
Healthy Subjects
Interventions
DRUG

Fezolinetant

Oral

Trial Locations (1)

21225

Parexel, Baltimore

All Listed Sponsors
lead

Astellas Pharma Global Development, Inc.

INDUSTRY

NCT04641260 - A Study to Assess the Effect of Food With Fezolinetant in Healthy Female Participants | Biotech Hunter | Biotech Hunter